The Digital Vaccine project is a collaborative initiative driven by diverse and multidisciplinary researchers from Carnegie Mellon University with FriendsLearn and other esteemed partner institutions. Our team's expertise spans across Healthcare, Information Technology, Machine Learning, Statistics, Clinical Medicine, Public Health and Impact Evaluation. Together we strive to combat lifestyle diseases through cutting-edge research, with a shared vision of harnessing innovation for a healthier world.
Collaborative Partners
Meet the Digital Vaccine Team
Investing in Impact: Backers of Breakthroughs
The advancement of the Digital Vaccine Research initiative has been made possible through the generous support of many key organizations. Their unwavering commitment enables groundbreaking research that aims to revolutionize healthcare.
Remala Family Foundation - The pivotal efforts of the Digital Vaccine SCHOOL Project are made possible by the gracious funding provided by the Remala Family Foundation. The Remala Foundation work towards breaking generational cycles of poverty by supporting educational opportunities and access to healthcare in India, Washington state, and beyond. It extends support to universities with personal connections to the family by funding scholarship endowments.
- Richard King Mellon Foundation - In 2021, Carnegie Mellon University secured a substantial
$250,000 grant from the esteemed Richard King Mellon Foundation. Dr. Rema Padman oversees the R.K. Mellon Foundation grant, leading research collaboration with UPMC Children's Hospital and FriendsLearn. The DVx-T1D Project focuses on an AI-powered mobile game to improve T1D outcomes through improvement of game design and enhancement of its impact on pediatric nutrition, diabetes management and lifestyle behaviors. The grant from the Richard King Mellon Foundation stands as a testament to the foundation's commitment to pioneering research, emphasizing the importance of leveraging innovative technologies to transform healthcare outcomes.